SARC007 May 5, 2021 A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas TYPE OF SARCOMA: Chondrosarcoma, extra-skeletal myxoid chondrosarcoma or alveolar soft part sarcomaDRUG: Perifosine ACCRUAL STATUS: Completed OVERALL STUDY PRINCIPAL INVESTIGATOR:Dejka Araujo, MDMD Anderson Cancer Center CLINICALTRIALS.GOV IDENTIFIER: NCT00401388 FOR STUDY DETAILS AND ELIGIBILITY CRITERIA: CLINICALTRIALS.GOV To learn more about this study or to contact the study research staff: CONTACT SARC